The Anglonordic Life Science Conference XII (www.anglonordiclifescience.com) gives you the opportunity to meet 300 decision makers representing leading and upcoming R&D companies from the Anglo-Nordic region and international pharmaceuticals and investment firms. Members of the Oslo Cancer Cluster: PCI Biotech, Lytix Biopharma and Oncoimmunity will present. Guest Country 2015 is Spain, who will participate with […]
Contact Team >
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.